{"url_path":"/sec/hcti/8-k/2026-06-15/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-15","source_url":"https://www.sec.gov/Archives/edgar/data/1839285/0001213900-26-068871-index.html","accession_number":"0001213900-26-068871","cik":"0001839285","ticker":"HCTI","issuer_name":"Healthcare Triangle, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1839285/0001213900-26-068871-index.html","primary_entity_key":"0001839285","primary_entity_name":"Healthcare Triangle, Inc."},"word_count":147,"has_tables":true,"body_markdown":"**Item 3.02 Unregistered Sales of Equity Securities.**\n\n \n\nThe information set forth under Item 1.01 of this\nCurrent Report on Form 8-K relating to the Note Offering, the Notes, the shares of Common Stock issuable upon conversion of the Notes,\nthe Equity Purchase Agreement, the Warrant and the shares of Common Stock issuable upon exercise of the Warrant is incorporated by reference\ninto this Item 3.02. The Notes, the shares issuable upon conversion of the Notes, the Warrant and the shares issuable upon exercise of\nthe Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities\nlaws and were offered and sold, or will be issued, in reliance upon exemptions from the registration requirements of the Securities Act,\nincluding Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities\nlaws."}